Key Events This Week
21 Sep: Upper circuit hit at Rs.201.02 (+5.0%) amid strong buying pressure
22 Sep: Another upper circuit at Rs.211.07 (+5.0%) with surge in delivery volumes
23 Sep: New 52-week high at Rs.223.85 and Mojo Grade upgraded to Hold
24 Sep: New 52-week high intraday at Rs.233.5, closed slightly lower at Rs.217.30 (-2.93%)
25 Sep: Recovery to Rs.223.55 (+2.88%) closing the week strongly

Broad-Based Technical Strength Lifts Kilitch Drugs (India) Ltd to 52-Week High of Rs 233.5
2026-09-24 09:40:09With a decisive surge to Rs 233.5 on 24 Jun 2026, Kilitch Drugs (India) Ltd has reached a fresh 52-week high, marking a 92.7% rally from its low of Rs 121.1 over the past year. This milestone comes amid a backdrop of broad technical alignment and sustained price momentum, even as the broader Sensex trades near its own 52-week lows.
Read full news article
Kilitch Drugs (India) Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-09-23 10:00:08At Rs 221.62, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5% on 23 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Broad-Based Technical Strength Lifts Kilitch Drugs (India) Ltd to 52-Week High of Rs 223.85
2026-09-23 09:46:05Kilitch Drugs (India) Ltd has surged to a new 52-week high of Rs 223.85 on 23 Sep 2026, marking a significant milestone after a sustained rally that has delivered over 27% returns in the past year. This advance comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades cautiously below key moving averages.
Read full news article
Kilitch Drugs Upgraded to Hold as Technicals Improve Despite Mixed Financials
2026-09-23 08:01:46Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting notable improvements in technical indicators and a reassessment of valuation metrics despite recent financial headwinds. This shift comes amid a bullish technical trend, an expensive yet justified valuation, and a stable financial outlook, positioning the micro-cap pharmaceutical firm for cautious investor interest.
Read full news article
Kilitch Drugs (India) Ltd Technical Momentum Shifts to Bullish Amid Strong Price Gains
2026-09-23 08:00:35Kilitch Drugs (India) Ltd has demonstrated a notable shift in price momentum, with technical indicators signalling a transition from mildly bullish to bullish territory. The stock’s recent 5.00% gain and upgrades across key metrics suggest renewed investor interest amid a challenging pharmaceutical sector backdrop.
Read full news article
Kilitch Drugs Valuation Shifts Signal Changing Market Perception
2026-09-23 08:00:10Kilitch Drugs (India) Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting evolving investor sentiment amid robust price gains and improving financial metrics. This article analyses the recent changes in key valuation ratios, compares them with industry peers, and assesses the implications for investors considering this micro-cap pharmaceutical player.
Read full news article
Kilitch Drugs Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent
2026-09-22 10:00:08At Rs 211.07, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5.0% on 22 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article






